AI and machine learning are still in the early stages of adoption as automation solutions for healthcare revenue cycle management. What will the future hold? Compared to older approaches to automation, such as robotic process automation and EHR add-ons, AI-based platforms will enable providers to more efficiently solve a full range of use cases across the revenue cycle, from predicting denials to capturing and interpreting patient data.
Artificial intelligence (AI) and machine learning (ML) are the newest frontiers in healthcare automation. This is especially true on the operational side, which has traditionally been underserved by AI and ML compared to other healthcare industry domains such as drug discovery and preliminary disease diagnosis.
Given the explosion of technological growth in this area, what will the future hold? Here’s what innovation-focused organizations need to be aware of as they plan ahead for using AI and automation in healthcare.
Accenture’s top 10 applications of AI in healthcare for 2021 included just one operations-related concept (“administrative workflow assistance”), even as the health AI market as a whole has grown tenfold from 2014 to 2021.
Machine learning is reinventing the healthcare revenue cycle.
~ Grant Messick, VP of Customer Success at AKASA
The current usage of AI and automation in healthcare across the revenue cycle is well established. Organizations use it to automate transactional tasks such as payer follow-ups after learning from data and workflows within staff systems. But it is still relatively limited in total adoption.
About 40% of healthcare systems aren’t currently using automation in their revenue cycle workflows, according to an AKASA survey. But more than 60% of that group plan to incorporate automation by the end of this year.
As AI automation in healthcare expands and evolves through new technologies, it will take on even the most complex RCM activities for hospitals and health systems.
An AI system applies human-like perception, interpretation, and decision-making to tasks via algorithms, while ML adapts to new information without human intervention.
With these capabilities, AI and ML solutions will perform the manual processes that characterize the typical revenue cycle and those previously done by less advanced types of “automation,” like robotic process automation (RPA).
“Automation” has often been a nebulous term when describing the long-term conversion of manual revenue cycle processes into more structured, automated workflows. Data-driven AI and ML automation get grouped with RPA, even though the two have very different technical architectures that determine what tasks they can perform.
About 60% of health systems and hospital financial leaders mistakenly consider RPA to be a form of AI, according to an AKASA-commissioned survey.
Here are some of the ways these technologies have been used in the revenue cycle — and opportunities for growth in the future.
To see the gap, consider the activities most commonly assigned to a traditional RPA bot, which is the current form of automation many healthcare organizations rely on:
No AI- or ML-powered intelligent automation is involved in any of these basic, linear activities. That means there is no adaptive human-like intelligence to continuously adjust to and learn from events and then determine the right path forward when (not if) anything changes across the multiple platforms involved. Something as simple as a new page layout or software update can break an RPA bot and require expensive consulting to remediate.
Learn why trying to build a rules-based engine to manage denials with RPA is like trying to map the stars.
In contrast, look at these four emerging use cases for AI-powered intelligent automation on the operational side:
In addition to these new use cases, AI and ML can also take on various other tasks. That includes but is not limited to cash posting, charge reconciliation, and utilization. AI and ML, paired with RPA, results in automation that can do everything from the basic to the complex, with none of the linearity and fragility of traditional RPA.
Moreover, AI and ML enable automation that’s purpose-built for the healthcare revenue cycle. This nuance is an essential differentiator from RPA, which is a form of automation ported from other sectors, with a one-size-fits-all approach that often breaks down when confronted with the particular complexities of RCM operations.
Only such purpose-built intelligent automation, powered by AI and ML, can scale to the current and future challenges that a healthcare organization will face throughout the increasingly burdened revenue cycle.
The traditional combination of manual processes, consultants, bolt-on additions to EHR systems, and — most recently — RPA bots has not yielded the performance that providers need, as benchmarked against their most important metrics:
Many of KLAS’s respondents also cited the COVID-19 pandemic as a catalyst for considering AI and ML platforms because it had exerted new financial pressure on them while compounding existing problems.
Going forward, automation via AI and ML can reduce initial denial rates and average days in accounts receivable in ways that other automation can’t, by:
With RPA, healthcare professionals and consultants must write strict instructions for each bot, often with only a limited amount of information about the overall operational environment. That’s a recipe for eventual breakdown.
AI and ML automation, however, is much more flexible and robust, as it takes in current environmental data more efficiently than any documentation process could and then comprehensively analyzes it. Critical workflows get captured in full and connected to an AI algorithm.
Instead of assuming that a script is still correct or that it can reliably scale to the sheer complexity of an RCM task, AI-driven automation is constantly learning and re-adapting.
Using AI and ML, broken workflows can be fixed and fresh ones automatically constructed, with a level of sophistication that could not be scripted by hand. Retrospective and prospective user actions are analyzed to continually refine how workflows are completed so that they’re as accurate as possible for every plan and code.
For tasks such as predicting denials, deep learning (a subset of machine learning) within an RCM automation solution provides a level of statistical and scientific rigor beyond what older types of automation can deliver, opening up entirely new use cases. This technical ability to learn from large quantities of changing data makes an AI solution for automation both reliable and future-proof: It can estimate probabilities based on specific information and adjust to any changes in user behavior and system characteristics.
Read about Deep Claim, an AKASA machine learning denials prediction model that predicts whether, when, and how much a payer will pay for a given hospital expense or claim. It was presented at the International Conference of Machine Learning in 2020.
Human experts are vital for properly training the AI and ensuring that it can handle the outliers that are an inevitable part of the revenue cycle. These humans in the loop can provide rapid resolution of unusual issues and also re-optimize the automation workflows in question so that next time they can adapt and handle the problem on their own. Eventually, AI and ML become capable of self-assigning accounts within RCM and billing systems and completing entire tasks once done by hand.
When implemented, AI-driven automation solutions should not only reduce your overall costs but also improve the accuracy of the work completed and improve performance against your key performance indicators.
~ Amy Raymond, VP of Revenue Cycle Operations at AKASA
The healthcare industry has been on an automation journey for decades, but its pace has sharply accelerated in recent years.
A 2021 Guidehouse Center for Health Insights survey of revenue cycle leaders found that 50% of them had deployed some form of automation to healthcare with operational and financial performance, up from only 15% in 2020. This significant increase, in only twelve months, illustrates the profound effects of COVID-19 on the healthcare industry and the newfound incentives to automate more manual processes previously assigned to short-staffed and often overburdened teams.
Although the impetus for increased automation is there, healthcare executives must thoroughly evaluate the technical capabilities within related products. A future-focused AI automation solution and partner should have:
AKASA brings all of these components together under the banner of Unified Automation®, a purpose-built platform that unites AI and ML in the cloud with human expertise. We empower providers on their journey toward a more automated revenue cycle that helps teams focus on the most value-generating activities.
Focusing teams in the most effective ways will have a broader impact on revenue cycle success. Learn more about how AI and Unified Automation can help your organization by scheduling a demo with AKASA.
AKASA recently announced a new collaboration with Cerner, a global healthcare technology company. Cerner customers now have access to...
The cost of healthcare in the United States is already astronomical, reaching 4.1 trillion in 2020. But add in...
Health spending in the United States is the highest in the world and expected to reach $4.5 trillion this...
Advances in healthcare are frequent, with new discoveries in medicine and treatment often capturing headlines. The healthcare revenue cycle...
Healthcare revenue cycle management in the United States continues to be plagued by a host of challenges that affect...
Last week, HIMSS Global Health Conference and Exhibition, the annual premier event that brings together thousands of healthcare industry leaders...
How Automation Empowers Efficient Revenue Cycle Management Why is the revenue cycle management process important in healthcare? In short,...